Timothy Rolph Akero Therapeutics, Inc. (AKRO) insider trading activity

AKRO Quotes by TradingView

Timothy Rolph is Chief Scientific Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 180,705 shares of AKRO, which is worth approximately $5.1 Million. The most recent transaction as insider was on Sep 13, 2022, when has been sold 22,500 shares (Common Stock) at a price of $29.18 per share, resulting in proceeds of $656,550. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 181K
0.3% 3M change
19.92% 12M change
Total Value Held $5.1 Million

Timothy Rolph Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2022
SELL
Open market or private sale
$656,550 $29.18 p/Share
22,500 Reduced 9.13%
223,837 Common Stock
Jun 30 2022
BUY
Grant, award, or other acquisition
$9,251 $8.03 p/Share
1,152 Added 0.47%
246,337 Common Stock
Jun 30 2021
BUY
Grant, award, or other acquisition
$21,238 $21.09 p/Share
1,007 Added 0.41%
245,185 Common Stock
Jun 30 2020
BUY
Grant, award, or other acquisition
$21,252 $17.07 p/Share
1,245 Added 0.51%
244,178 Common Stock
TR

Timothy Rolph

Chief Scientific Officer
South San Francisco, CA

Track Institutional and Insider Activities on AKRO

Follow Akero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKRO shares.

Notify only if

Insider Trading

Get notified when an Akero Therapeutics, Inc. insider buys or sells AKRO shares.

Notify only if

News

Receive news related to Akero Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKRO